Full Text
PIN4 COST-BENEFIT ANALYSIS OF OSELTAMIVIR VERSUS NO ANTIVIRAL TREATMENT FROM THE EMPLOYER PERSPECTIVE-THE ROCHE BRAZIL CASE

Abstract

Authors

AC Moreno MG Saggia EA Santos S Rodrigues

Back to Volume 10, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×